NIAID's Antimicrobial Acquisition and Coordinating Facility AACF

AACF Home Screening Assays Medicinal Chemistry Participating Organizations Submission Info Screening Agreement Compound Submission Form Contact Info

Participating Organizations The NIAID antiviral program consists of various integrated components: Southern Research Institute: Candidate compound identification and acquisition services; Principal Investigator: Dr. Jack Secrist.   University of Alabama Birmingham: Orthopoxvirus,  herpesvirus, and in vivo screening services; Principal Investigators: Dr. Mark Prichard and Dr. Debra Quenelle.   Utah State University:  Biodefense, respiratory virus, and in vivo screening services; Principal Investigators: Dr. Donald Smee and Dr. John Morrey.   Georgetown University: Hepatitis B screening services.  Hepatitis C screening services; Principal Investigator: Dr. Brent Korba.   University of Pittsburgh: BK virus screening services; Principal Investigator: Dr. Parmjeet Randhawa.   Penn State University: Papillomavirus screening services; Principal Investigator: Dr. Neil Christensen.   Southern Research Institute - Frederick: Hepatitis C and high and low-throughput anti-SARS screening services.  Hepatitis B screening services; Principal Investigator: Dr. Michael Murray. University of Rochester Medical Center:  In vivo human papilloma virus screening services; Principal Investigator:  Dr. William Bonnez, M.D. Cincinnati Children's Hospital Medical Center:  In vivo cytomegalovirus and herpesvirus screening services; Principal Investigator:  Dr. David Bernstein. St. Louis University:  In vivo screening services;  Principal Investigator:  Dr. R. Mark L. Buller. Baylor College of Medicine:  In vivo screening services;  Principal Investigator:  Dr. Brian Gilbert.

© Copyright, 2003, The National Institute of Allergy and Infectious Diseases (NIAID). All rights reserved.
To report problems with this site, contact the webmaster.